ONPATTRO® (patisiran) Provides an approved RNAi treatment for adults with hereditary transthyretin amyloidosis polyneuropathy, reducing production of the transthyretin protein underlying disease.
Visit productCosigns Received
Be the first Cosign
Put your name behind ONPATTRO® (patisiran).
Add it to your Products I use list and share why you use it.